Shima Hadidchi, MD , a board-certified physician, will guide you through this process and provide personalized care to ensure a smooth transition
Another limitation is the a priori exclusion of long-term cardiovascular or mortality outcomes from our analysis, a decision based on the fact that the dedicated cardiovascular outcomes trial for tirzepatide (SURPASS-CVOT) is still ongoing [60]
Patient safety considerations include monitoring for dehydration, especially if laxative use leads to loose stools or diarrhea in someone already experiencing nausea or reduced fluid intake
Norepinephrine and arousal Norepinephrine is the neurotransmitter of physiological arousal, the racing heart, the heightened sensation, the bodily readiness for sexual activity
At this time, Ozempic does not have FDA approval for weight loss, but it may be prescribed off-label for this purpose
Patch testing was performed that was negative